Cargando…

Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder

Major depressive disorder (MDD) is the most common psychiatric disorders. However, a biochemical marker has yet to be established for clinical purposes. It is proposed that lysophosphatidic acid (LPA, 1-acyl-2-sn-glycerol-3-phosphoate) plays some important roles in emotional regulation of experiment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gotoh, Leo, Yamada, Misa, Hattori, Kotaro, Sasayama, Daimei, Noda, Takamasa, Yoshida, Sumiko, Kunugi, Hiroshi, Yamada, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526395/ https://www.ncbi.nlm.nih.gov/pubmed/31193411 http://dx.doi.org/10.1016/j.heliyon.2019.e01699

Ejemplares similares

Increased cerebrospinal fluid fibrinogen in major depressive disorder
por: Hattori, Kotaro, et al.
Publicado: (2015)

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2015)

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers
por: Sasayama, Daimei, et al.
Publicado: (2020)

PS195. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2016)

Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study
por: Hidese, Shinsuke, et al.
Publicado: (2021)

PS238. Altered balance between monoamine metabolites in human cerebrospinal fluid with major depressive disorder.
por: Yoon, Hyung Shin, et al.
Publicado: (2016)

Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
por: Hidese, Shinsuke, et al.
Publicado: (2020)

PM539. Evaluation of plasma and cerebrospinal fluid G72 protein levels and their correlations with psychiatric symptoms in schizophrenia and major depression
por: Ishiwata-Matsushima, Sayuri, et al.
Publicado: (2016)

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

Reduced plasma orexin-A levels in patients with bipolar disorder
por: Tsuchimine, Shoko, et al.
Publicado: (2019)

Profiling of Cerebrospinal Fluid Lipids and Their Relationship with Plasma Lipids in Healthy Humans
por: Saito, Kosuke, et al.
Publicado: (2021)

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder
por: Itagaki, Kei, et al.
Publicado: (2019)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses
por: Hori, Hiroaki, et al.
Publicado: (2016)

(13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder
por: Teraishi, Toshiya, et al.
Publicado: (2015)

Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population
por: Sasayama, Daimei, et al.
Publicado: (2011)

Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults
por: Sasayama, Daimei, et al.
Publicado: (2011)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
por: Ahmad, Shahzad, et al.
Publicado: (2020)

Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study
por: Kageyama, Yuki, et al.
Publicado: (2021)

Identification of Single Nucleotide Polymorphisms Regulating Peripheral Blood mRNA Expression with Genome-Wide Significance: An eQTL Study in the Japanese Population
por: Sasayama, Daimei, et al.
Publicado: (2013)

Relationship between Lifetime Suicide Attempts and Schizotypal Traits in Patients with Schizophrenia
por: Teraishi, Toshiya, et al.
Publicado: (2014)

Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review
por: Kawashima, Yoshitaka, et al.
Publicado: (2023)

Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
por: Yamada, Risa, et al.
Publicado: (2023)

Possible association between photic sneeze syndrome and migraine and psychological distress
por: Sasayama, Daimei, et al.
Publicado: (2019)

Possible association between common variants of the phenylalanine hydroxylase (PAH) gene and memory performance in healthy adults
por: Teraishi, Toshiya, et al.
Publicado: (2013)

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders
por: Araki, Wataru, et al.
Publicado: (2017)

Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals
por: Hori, Hiroaki, et al.
Publicado: (2012)

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
por: Hidese, Shinsuke, et al.
Publicado: (2022)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Cerebrospinal fluid physiology: visualization of cerebrospinal fluid dynamics using the magnetic resonance imaging Time-Spatial Inversion Pulse method
por: Yamada, Shinya
Publicado: (2014)

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
por: Nagata, Yuki, et al.
Publicado: (2018)

Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases
por: Hoshi, Kyoka, et al.
Publicado: (2023)

Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls
por: Aizawa, Emiko, et al.
Publicado: (2019)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Cerebrospinal Fluid Production and Absorption and Ventricular Enlargement Mechanisms in Hydrocephalus
por: YAMADA, Shigeki, et al.
Publicado: (2023)

Speaker 2: Kotaro Hattori, Japan
por: Hattori, Kotaro, et al.
Publicado: (2016)

Hypothalamic-pituitary-adrenal axis and renin-angiotensin-aldosterone system in adulthood PTSD and childhood maltreatment history
por: Kakehi, Ryoko, et al.
Publicado: (2023)

Relationship of food allergy with quality of life and sleep in psychiatric patients
por: Gomi, Chiho, et al.
Publicado: (2022)

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023)

PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g940dmchjkpi6n2f71nrbikduu